DEUTSCHE BANK AG\ - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 161 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$2,105,115
-47.5%
63,388
-50.2%
0.00%
-50.0%
Q3 2022$4,010,000
+436.1%
127,188
+417.3%
0.00%
Q2 2022$748,000
+9.4%
24,589
-6.6%
0.00%
Q1 2022$684,000
-60.2%
26,335
-68.7%
0.00%
-100.0%
Q4 2021$1,717,000
+224.0%
84,175
+205.6%
0.00%
Q3 2021$530,000
-15.7%
27,545
-2.8%
0.00%
Q2 2021$629,000
-22.1%
28,338
-7.9%
0.00%
Q1 2021$807,000
+26.3%
30,763
-10.0%
0.00%
Q4 2020$639,000
+42.3%
34,199
+29.4%
0.00%
Q3 2020$449,000
-19.7%
26,434
+10.2%
0.00%
Q2 2020$559,000
-78.2%
23,984
-92.2%
0.00%
-100.0%
Q1 2020$2,568,000
-24.6%
305,738
-12.3%
0.00%0.0%
Q4 2019$3,404,000
+348.5%
348,708
+334.2%
0.00%
+100.0%
Q3 2019$759,000
-44.7%
80,311
-30.6%
0.00%0.0%
Q2 2019$1,373,000
-52.5%
115,755
-29.5%
0.00%
-50.0%
Q1 2019$2,888,000
+38.1%
164,108
+36.1%
0.00%
+100.0%
Q4 2018$2,091,000
-72.6%
120,581
-76.5%
0.00%
-50.0%
Q3 2018$7,635,000
-31.7%
512,507
-27.1%
0.00%
-33.3%
Q2 2018$11,178,000
+53.6%
703,154
+37.2%
0.00%0.0%
Q1 2018$7,276,000
+23.4%
512,591
+21.7%
0.00%
-25.0%
Q4 2017$5,898,000
+109.6%
421,354
+113.9%
0.00%
+100.0%
Q3 2017$2,814,000
+19.8%
196,995
+32.0%
0.00%0.0%
Q2 2017$2,348,000
+30.4%
149,211
+14.3%
0.00%
+100.0%
Q1 2017$1,800,000
-42.7%
130,561
-26.5%
0.00%
-66.7%
Q4 2016$3,141,000
-12.6%
177,530
-4.7%
0.00%0.0%
Q3 2016$3,592,000
+45.4%
186,293
+46.9%
0.00%
+50.0%
Q2 2016$2,471,000
+22.8%
126,834
+29.8%
0.00%0.0%
Q1 2016$2,013,000
-40.8%
97,751
-41.1%
0.00%0.0%
Q4 2015$3,401,000
-4.2%
165,876
-20.2%
0.00%
-33.3%
Q3 2015$3,551,000
+36.3%
207,831
+48.5%
0.00%
+50.0%
Q2 2015$2,606,000
+32.4%
139,919
+35.6%
0.00%
+100.0%
Q1 2015$1,968,000
-62.3%
103,206
-67.5%
0.00%
-66.7%
Q4 2014$5,221,000
+21.4%
317,325
+30.5%
0.00%0.0%
Q3 2014$4,299,000
+4.2%
243,100
+21.6%
0.00%0.0%
Q2 2014$4,126,000
-30.9%
199,958
-27.0%
0.00%
-25.0%
Q1 2014$5,972,000
+90.9%
274,090
+132.4%
0.00%
+100.0%
Q4 2013$3,128,000
-7.7%
117,928
-17.8%
0.00%
-33.3%
Q3 2013$3,388,000143,4130.00%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q1 2015
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders